NCT05739331 Augmented Endobronchial Ultrasound (EBUS-TBNA) With Artificial Intelligence
| NCT ID | NCT05739331 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Norwegian University of Science and Technology |
| Condition | Artificial Intelligence |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2027-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2023-05-01 with a primary completion date of 2027-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the usefulness of Deep neural network (DNN) in the evaluation of mediastinal and hilar lymph nodes with Endobronchial ultrasound (EBUS). The study will explore the feasibility of DNN to identify lymph nodes and blood vessel examined with EBUS.
Eligibility Criteria
Inclusion Criteria: * Subjects referred to thoracic department in any of the participating hospitals with undiagnosed enlarged mediastinal and hilar lymph nodes. * Subjects have to be ≥ 18 years of age Exclusion Criteria: * Pregnancy * Any patient that the Investigator feels is not appropriate for this study for any reason.
Contact & Investigator
Øivind Rognmo, Dr.philos
STUDY DIRECTOR
Norwegian University of Science and Technology
Frequently Asked Questions
Who can join the NCT05739331 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Artificial Intelligence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05739331 currently recruiting?
Yes, NCT05739331 is actively recruiting participants. Contact the research team at oyvind.ervik@ntnu.no for enrollment information.
Where is the NCT05739331 trial being conducted?
This trial is being conducted at Levanger, Norway, Trondheim, Norway.
Who is sponsoring the NCT05739331 clinical trial?
NCT05739331 is sponsored by Norwegian University of Science and Technology. The principal investigator is Øivind Rognmo, Dr.philos at Norwegian University of Science and Technology. The trial plans to enroll 50 participants.